Cumberland Pharmaceuticals Inc. (CPIX) vs OnKure Therapeutics, Inc. (OKUR)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and OnKure Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.09HealthcareDelayed quote: Oct 6, 2026, 12:53 PM EDT
OKUR
OnKure Therapeutics, Inc.
$2.53HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — CPIX vs OKUR
growth of $100 · dividends reinvested · last 5yCPIX +179.2% (+22.8%/yr)OKUR -98.2% (-55.5%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX OKUR
CPIX vs OKUR: by the numbers
- •CPIX is the larger company ($106M vs $102M market cap).
- •Both run net losses; OKUR's is the smaller (0.00% vs -33.92% net margin).
- •CPIX pays a dividend (21.16% yield), while OKUR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | OKUR |
|---|---|---|
| P/S ratio | 3.40 | N/A |
| P/B ratio | 6.09 | 0.59 |
Profitability
| Metric | CPIX | OKUR |
|---|---|---|
| Gross margin | 83.37% | 0.00% |
| Operating margin | -6.27% | 0.00% |
| Net margin | -33.92% | 0.00% |
| ROE | -60.82% | -34.11% |
| ROIC | -34.77% | -35.98% |
Dividends
| Metric | CPIX | OKUR |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | OKUR |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | -47.19% |
Frequently asked
- Does CPIX or OKUR pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while OKUR has no payments in the available dividend history.
- How have CPIX and OKUR total returns compared?
- Over the past 5 years, CPIX delivered 25.62% and OKUR delivered -47.19% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEOnKure Therapeutics ROECumberland Pharmaceuticals operating marginOnKure Therapeutics operating marginCumberland Pharmaceuticals revenue growthOnKure Therapeutics revenue growthCumberland Pharmaceuticals free cash flowOnKure Therapeutics free cash flow
Cumberland Pharmaceuticals & OnKure Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.